Insmed Incorporated is an American biotechnology company focused on the development and commercialization of innovative therapies for patients suffering from rare and serious diseases. The company specializes in the treatment of lung diseases, particularly pulmonary hypertension and rare pulmonary infections, using advanced biologic and pharmaceutical products. Insmed is known for its work to improve the quality of life for patients who have no effective treatment options and focuses on developing new drugs for diseases that remain insufficiently treated.